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Abstract
The sharp dose gradients in intensity-modulated radiation therapy increase the treatment sensitivity to
various inter- and intra-fractional uncertainties, in which a slight anatomical change may greatly alter
the actual dose delivered. Image-guided radiotherapy refers to the use of advanced imaging techniques
to precisely track and correct these patient-specific variations in routine treatment. It can also monitor
organ changes during a radiotherapy course. Currently, image-guided radiotherapy using computed to-
mography has gained much popularity in radiotherapy verification as it provides volumetric images with
soft-tissue contrast for on-line tracking of tumour. This article reviews four types of computed tomo-
graphy-based image guidance systems and their working principles. The system characteristics and
clinical applications of the helical, megavoltage, computed tomography, and kilovoltage, cone-beam,
computed tomography systems are discussed, given that they are currently the most commonly used
systems for radiotherapy verification. This article also focuses on the recent techniques of soft-tissue
contrast enhancement, digital tomosynthesis, four-dimensional fluoroscopic image guidance, and kilo-
voltage/megavoltage, in-line cone-beam imaging. These evolving systems are expected to take over the
conventional two-dimensional verification system in the near future and provide the basis for imple-
menting adaptive radiotherapy.
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INTRODUCTION
The success of radiotherapy heavily depends on
the accuracy of delivering the prescribed dose to
the target volume while sparing normal tissues
during all phases of treatment. However, this
can be difficult, given the uncertainties during
treatment. These uncertainties may result in dis-
crepancies in dose distribution between treat-
ment and planning and, therefore, cannot
deliver the intended dose of radiation to the tar-
get. In general, treatment uncertainties can
occur between or during treatments, that is,
inter- and intra-fractional errors. The inter-frac-
tional errors most commonly arise from external
setup variation and patient motion, which can
be present in all treatment sites. It may also be
due to internal geometric and volumetric
changes throughout the fractionated radio-
therapy course. Many studies had proved that
there was tumour or shrinkage of organs at
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risk (OARs) and body-weight loss in head and
neck (HN) cancer patients, as well as tumour
regression in lung-cancer patients.13 For pelvic
treatment, the daily uncertainties can be
induced by the differential filling of bowel and
bladder, therefore compassing the tumours and
causing displacement and distortion,4,5 whereas
the intra-fractional breathing and cardiac
motion will lead to organ or tumour movement
in the chest and upper-abdomen region during
treatment.3,6 Clearly, the ability to correct
inter- and intra-fractional errors is important
to the accuracy of treatment in varies sites.
Leaving the radiotherapy uncertainties uncor-
rected may result in discrepancies between the
dose delivered and the dose planned, leading
to insufficient dose to the tumour and/or over-
dose to adjacent OARs. Intensity-modulated
radiation therapy (IMRT) provides highly con-
formal treatment with steep dose fall-off outside
target volume. It allows radiation-dose escala-
tion and increases the tumour-control rate.
However, the sharp dose gradients at boundar-
ies between target and surrounding OARs
increase the treatment sensitivity to errors, in
which a slight anatomical change may greatly
alter the actual dose delivered. Conventionally,
a generic margin has been added to the tumour
to ensure adequate dose delivery to it, however,
there is always the risk of many abutting normal
tissues getting unnecessarily irradiated. More-
over, these treatment inaccuracies can be
patient specific and may vary with different
degree and combination in each individual
case. All of these urged the development of
advanced imaging guidance systems in radio-
therapy.
According to Mackie et al.,7 image-guided
radiotherapy (IGRT) means continuous quality
improvement, using images to better achieve
the goals of radiation therapy. Image guidance
technique allows more precise tracking and cor-
rection of patient-specific variations over the
IMRT treatment course so that target margin
can be significantly reduced. Tumour dose
escalation can be carried out safely, and without
risking the surrounding normal tissues, which
ultimately minimises the normal tissue toxicity
and maximises the local tumour control. Image
guidance techniques also allow one to monitor
the organ changes during the course of radio-
therapy.
In-room (i.e. inside radiotherapy suite) image
guidance can be achieved by several methods
ranging from conventional portal imaging,3
ultrasound localisation,8 stereoscopic kilovol-
tage imaging,9 computed tomography (CT) to
some new, emerging techniques like electro-
magnetic marker-based localisation and track-
ing10 and 3-dimensional (3D) body-surface
imaging.11 Among them, in-room CT imaging,
which includes CT on rails, mega- and kilovol-
tage cone-beam (CB) CT, and helical megavol-
tage CT, has gained most popularity nowadays,
as it provides volumetric images with soft-tissue
contrast for on-line verification of tumour. This
article reviews the principles of these CT-based
image guidance systems and their recent devel-
opments. Among them, the system characteris-
tics and clinical applications of the
megavoltage CT and kilovoltage CBCT sys-
tems are discussed in greater depth because
they are currently the more commonly used
systems for radiotherapy verification.
IMAGE ACQUISITION AND
REGISTRATION
CT on rails
The most straightforward way to obtain volu-
metric CT images for treatment verification is
to install a conventional CT scanner in the
treatment room. One of the commercially
available models is the Siemens Primatom Sys-
tem (Erlangen, Germany). It consists of a Pri-
mus linear accelerator (LINAC) and a
Somatom CT scanner with sliding gantry,
with each unit located at one side of the patient
couch. After positioning the patient appropri-
ately, the couch is rotated 180 to the CT
bore. Image acquisition begins when the CT
scanner is driven on rails and travels across the
stationary patient lying on the couch. After
scanning, the CT gantry is retracted to its ori-
ginal position. The treatment couch is then
rotated backward such that the patient is under
the LINAC gantry for treatment delivery. The
imaging parameters of the CT on rails generally
resemble those of a conventional CT. The
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gantry can rotate up to 0.33 second per rotation
and travel along the rails with the speed varying
from 0.1 to 10 cm per second. The field-of-
view (FOV) of the CT scanner is 50 cm in dia-
meter.12
After image acquisition, the pre-treatment
CT images are fused with the planning CT
(PLCT) images using the image management
software for treatment verification. Both image
sets are displayed side by side on the computer
screen and can be viewed in transverse, coronal
and sagittal planes. The software allows auto-
matic and manual alignment to evaluate the iso-
centre shift in translational (lateral, longitudinal,
vertical) and rotational (yaw, pitch, roll) dimen-
sions. However, the current practice allows
only translations and yaw rotations. Therefore,
rotational adjustments, except for yaw direc-
tion, are being disabled in the registration soft-
ware during clinical use. In the mode of
automatic landmark registration, reference
points can be defined on those landmarks that
are easily identified on both sets of images for
alignment. For visual alignment mode, the
two image sets are overlapped such that they
can be aligned manually according to the ana-
tomical structures location. Structure contours
from the PLCT can also be displayed on the
verification images to aid the alignment pro-
cess.12,13 Normally the time needed for scan-
ning plus registration is about 7 to 8
minutes.14 The offsets measured by the registra-
tion system are then corrected by precise couch
motion before proceeding to treatment.
Megavoltage CBCT
Technical innovation in portal imaging system
recently allows the acquisition of volumetric
data, in addition to conventional 2-dimensional
(2D) images. The megavoltage (MV) CBCT
imaging utilises the radiation source of the
LINAC and the electronic portal imaging
device (EPID) for image acquisition. This pro-
vides a more compact system configuration
when compared to the CT-on-rails system.
During image acquisition, a series of portal
images (projections) are captured by the EPID
while the gantry rotates to place the patient
under treatment position. These projection
images are then reconstructed using the Feld-
kamp filtered back-projection algorithm15 to
give volumetric image set. The imaging energy
ranges between 2 and 8 MV, depending on the
output of the LINAC.14 Typically, the gantry
rotates at a speed of 6 per second, and one por-
tal image is obtained in each degree. The FOV
is 24 cm in diameter and 28 cm in longitudinal
dimension.16 Unlike conventional CT, partial
gantry rotation (e.g. 180 with 180 projections)
is possible for volumetric image reconstruction.
The acquisition procedure plus the time for
image read-out take about 1.5 to 3.0 minutes.
The imaging dose is estimated by the product
of total number of projections and the dose
delivered by one image, which is approximately
1 to 15 cGy.17,18
The reconstructed MVCBCT image set is
superimposed to that of the PLCT in the trans-
verse, coronal and sagittal planes for registration.
The MVCBCT is displayed in a different colour
scheme with adjustable transparency level such
that either one CT set or superimposed images
of both CT sets are visualised. Matching can
be carried out automatically by mutual informa-
tion algorithm.17,18 The anatomic landmarks
can also be aligned manually, and the structure
contours and isodose distribution can be dis-
played on the MVCBCT images for the fine-
tuning of the registration result. Again, the
LINAC couch motions allow only translational
and yaw correction, in spite of the registration
software’s ability to quantify the errors in all
six vectors.
Kilovoltage CBCT
Cone-beam reconstruction technique is also
applicable with the use of kilovoltage x-ray
source. Elekta Synergy (Crawley, United King-
dom) and Varian Trilogy (Palo Alto, USA) are
the two common systems that are mounted on
LINAC for pre-treatment kilovoltage (kV)
CBCT imaging. Both systems consist of a kV
x-ray tube and an amorphous silicon flat-panel
detector which is attached to the LINAC, per-
pendicular to the radiation-beam direction.
Other than volumetric imaging, these systems
also allow 2D radiography and fluoroscopy.
Similar to MVCBCT, the gantry with the
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x-ray tube is rotated once round the patient in
treatment position for image acquisition. Image
projections acquired by the detector are recon-
structed to give CBCT images. Most of the
imaging parameters for kVCBCT are variable.
In general, the imaging energy is ranged from
40 to 130 kVp and 25 to 100 mA, and the rota-
tion speed is 6 per second. The FOV is 50 cm
in diameter and 25 cm in longitudinal dimen-
sion. The system requires 1 to 3 minutes for
image acquisition. The imaging dose is 0.3 to
6.0 cGy, depending on the imaging parameters
employed.17,19,20 The image registration process
and the software design are similar to those used
in the MVCBCT system. Overlapped images in
three orthogonal planes are displayed for auto-
matic or manual fusion. After defining the setup
errors, corresponding couch adjustments are
then performed and patient is ready for
treatment.
Helical megavoltage CT
The helical megavoltage (MV) CT imaging is
provided by the Tomotherapy HI-ART System
(Madison, Wisconsin), which is an integration
of a LINAC and a CT scanner. Inside the ring
gantry, there is a short LINAC with a xenon
detector positioned in the opposite side. The
MVCT image acquisition process is similar to
that of conventional CT scanner: patient in
treatment position is continuously translated
through the gantry, with x-ray fan beam rotat-
ing above the patient. In the imaging mode,
the beam energy is detuned to 3.5 MV, and
full-gantry rotation (i.e. 360) is in a speed of
about 6 second per rotation.21 Depending on
the length of the scan region, the total scan
time requires 3 to 10 minutes (scan time ¼
number of slices x gantry rotation speed).7
The maximum FOV is 40 cm in diameter and
180 cm in longitudinal dimension. The imaging
dose is approximately 1 to 3 cGy.21,22
Similarly, the MVCT images are superim-
posed onto the corresponding PLCT images
and are displayed in a range of colours, and in
three orthogonal planes, for automatic or man-
ual alignment. According to the tomotherapy-
treatment-couch specification, correction of
the setup errors can only be carried out in the
translational dimensions. The roll correction is
addressed by modifying the initial gantry angle.
The pitch and yaw adjustments, though avail-
able in the software, are not used as currently
they can be corrected only by physically mov-
ing the patient. In practice, automatic registra-
tion will be carried out first, followed by
manual fine-tuning. The registration result can
be validated by matching the anatomical land-
marks on the two image sets or by displaying
the structure contours and isodose cloud on
the MVCT image set, to ensure correct dose
is delivered to the intended area. According to
the registration result, the couch and the initial
gantry angle are adjusted automatically before
the start of treatment.
COMPARISON BETWEEN MVCT
AND KVCBCT
An ideal image guidance system is able to gen-
erate high-quality images with low imaging
dose, which can accurately detect and quantify
the patient-positioning errors as well as internal
organ displacement and deformation. More-
over, the system should allow fast and accurate
correction of the errors detected. The system
performances of MVCT and kVCBCT are
compared in terms of hardware configurations
and specifications, image quality, and imaging
dose (Table 1).
Hardware configurations and
specifications
MVCT images are in exact geometric coincid-
ence with the treatment because same x-ray
source is used for imaging and treatment. But
for kVCBCT, which uses an isolated kV x-ray
source, cross-isocentre calibration is needed.23
The maximum longitudinal FOV of 180 cm
makes MVCT suitable for verifying prolonged
treatment area, whereas kVCBCT with a lim-
ited detector length (25 cm) may require two
scans for a long treatment region. Nevertheless,
kVCBCT has a faster image-acquisition time, as
it images the whole volume with a single gantry
rotation. The ring-gantry design allows a full
unobstructed gantry rotation in MVCT,
whereas the retraction and extraction of the
CBCT detector arm involves the risk of
124
Image-guided radiation therapy using computed tomography in radiotherapy
collision. Moreover, for CBCT, when scanning
laterally situated target, for example, breast and
limbs, with patient positioned to one side on
the couch, only partial gantry rotation is pos-
sible, which in turn may degrade the image
quality.
MVCT and kVCBCT volumetric imaging
allows detection of rotational errors that may
be missed in the conventional orthogonal planar
match. However, the physical restriction of the
couch in yaw and/or pitch adjustment not only
reduces the registration accuracy but also
increase the setup errors in translational dimen-
sions. A yaw offset without correction during
fusion will increase the lateral shift, whereas un-
corrected pitch errors will increase the vertical
and longitudinal shifts.24 Effort has been put in
developing the pitch and yaw correction algo-
rithm for tomotherapy couch in order to elim-
inate possible errors during the process of
physical patient adjustment.25 A hexapod
robotic treatment couch, which allows pitch,
roll and yaw correction up to 3, is now avail-
able to complement CBCT.26
Image quality
The volumetric images provided by the MVCT
and kVCBCT systems give superior soft-tissue
visualisation over the conventional EPID veri-
fication.18,27 This advantage allows direct meas-
urement of organtarget variation instead of
using bony structures as surrogates. Moreover,
the 3D images are readily comparable to the
PLCT images in a slice-by-slice fashion in dif-
ferent viewing planes. Errors in various direc-
tions and organ deformation can be easily
detected.
With the scan time of greater than 1 minute,
both MVCT and kVCBCT are classified as
slow CT systems. That means, whenever there
is an intra-scanning motion, for example,
breathing, there will be artefacts like blurring,
doubling and distortion which degrade the
image quality and affect target localisation
accuracy. Nonetheless, both MVCT and
kVCBCT images have been demonstrated to
give sufficient details for setup verification and
delineation of certain soft-tissue organs.19,21
A study by Meeks et al.28 on MVCT imaging
performance reported that the uniformity and
spatial resolution of MVCT images were com-
parable to kVCT images, but not the ones
with low-contrast resolution. This is due to
the Compton scattering effect on MV energies,
which results in poorer soft-tissue contrast. For
kVCBCT, the dominant photoelectric (PE)
radiation effect, which depends on atomic
Table 1. Summary of the comparison between the system performances of MVCT and kVCBCT in terms of hardware configurations and
specifications, image quality and imaging dose.
MVCT kVCBCT
Hardware configurations and
specification
Setup-error detection by soft-
ware
3 translational þ 3 rotational
directions
Physical couch adjustments 3 translational directions
X-ray source Same as treatment source Separated from treatment source
Longitudinal FOV 180 cm 25 cm
Image acquisition time 310 minutes 13 minutes
Collision risks NA Yes
Images dimensions 3-dimensions (volumetric
images)
Intra-scanning motion
artifacts
Yes
Uniformity & spatial resolution Comparable
Image quality Radiation interaction Compton scattering Photoelectric effect
Contrast resolution Relatively low Relatively high
Imaging of metallic implants Clear images Signal loss/Streaks in images
Imaging dose 13 cGy 0.36.0 cGy
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number, facilitates better soft-tissue visualisation
in the images. However, kVCBCT may not be
favourable for patients with metal implants, for
example, dental filling and hip prosthesis. Due
to the inherent PE effect on kV energies,
beam-hardening and clipping artefacts are vis-
ible around the metallic objects, which results
in signal loss or dramatic streaks. Conversely,
Compton scattering allows MVCT to give bet-
ter results under this circumstance: clear images
showing the implants, and nearby bony and
soft-tissue anatomy seen with only a slightly
degraded image quality.
In kVCBCT, the imaging parameters are
variable, depending on the image quality
required and the dose to be delivered to the
patient. In terms of patient’s size and anatomical
sites, a large or thick body region like pelvis has
great x-ray attenuation and, therefore, requires
higher energy for acceptable image quality.
Image quality can be improved by using smaller
FOV, as there are fewer chances of scatter;
higher current for reduced noise; and greater
range of gantry rotation, with slower rotation
speed for more image projections. However,
the increase in energy and beam-on time (to
get more projections) inevitably gives higher
imaging dose to patient, which requires critical
consideration during the scanning process.
Moreover, the imaging performance of
kVCBCT is particularly affected by the use of
flat-panel detector and the cone-beam geo-
metry. Unlike conventional CT detector, the
flat-panel detector has only limited dynamic
range. The large variation of x-ray fluence pas-
sing through the body can overwhelm the
detector-signal range at the periphery and can,
in turn, cause signal saturation. This in turn
leads to information loss during image acquisi-
tion and image artefacts due to truncation of
anatomy.17 The cone-beam geometry also gen-
erates severe scatter radiation in patient that
reaches the detector. The scatter component
increases with large FOV and irradiated vol-
ume, for example, pelvis region, and reduces
the image contrast to noise ratio with distracting
shading artefacts. The signal loss together with
the scatter deteriorate the overall uniformity,
low-contrast visibility and CT-number accur-
acy in kVCBCT images; therefore, the image
quality of kVCBCT is inferior to that of con-
ventional CT.
Imaging dose
In standard scanning condition, the dose per
scan from MVCT and kVCBCT are 1 to 3
cGy and 0.3 to 6.0 cGy, respectively. This dos-
age is comparable to those using orthogonal
MV radiographs for verifying setup.20 How-
ever, for highly precise IGRT, daily imaging is
performed and results in substantial accumulat-
ing dose, which may exceed 1 Gy in 30 frac-
tions of treatment. Moreover, MVCT and
kVCBCT irradiate a much larger volume than
do MV radiographs. As a result, it is difficult
to include the imaging dose in the treatment-
dose regimen, as in the case of MV portal
imaging.19 The daily large-volume irradiation
also results in significant dose delivery to adja-
cent normal tissues and increase the probability
of causing secondary cancer to areas that were
non-malignant before dose delivery.20 For veri-
fying laterally situated target, the contralateral
tissues are unnecessarily being irradiated during
full gantry rotation. kVCBCT imaging was
found to contribute greater than 1 cGy peri-
pheral dose per scan (i.e. dose outside the
imaged volume),29 and a similar result for
MVCT is also likely. Therefore, the risk of sec-
ondary malignancies should be weighed against
the potential clinical benefit of using these
image guidance systems for setup verification.
For kVCBCT, reducing the energy, number
of projection, FOV and partial gantry rotation
for a given scan can minimise in-field and peri-
pheral dose. For MVCT, the imaging dose can
be reduced by shortening the longitudinal
FOV or lowering the machine output. If high
dose is unavoidable, the extra imaging dose
can be calculated and factored into the dose tol-
erance during treatment planning for critical
organs such as the lens, or the other option
would be to reduce the imaging frequency.
CLINICAL APPLICATIONS OF
THE MVCT AND KVCBCT
SYSTEMS
In the following, the clinical applications of the
MVCT and kVCBCT imaging systems in the
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management of inter-fractional uncertainties are
thoroughly reviewed. The two systems are dis-
cussed separately under their applications of
three body regions, which are the head and
neck (HN) region, thoracic and upper-
abdomen region, and pelvic region.
Head and neck (HN) region
Basically, organ motion is not an issue for this
region, and the setup uncertainties are relatively
small due to a more rigid immobilisation sys-
tem. The major challenge for IGRT here is to
detect the tumour or adjacent organ shrinkage
and body-weight loss that consequently lead to
target/OARs dose discrepancies during the
treatment course. Other than the tumour itself,
the surrounding bony landmarks can also be
used as reliable surrogates for treatment verifica-
tion, owing to their more stable geographical
relationship with the tumour.
MVCT allows good contrast between bone,
soft tissues and air cavities in the HN region,
which makes image fusion easier in this region
than is possible in other anatomical sites.
Although images are more grainy compared to
kVCBCT, the tumour volume is clearly visible,
especially for those situated in air-filled sinus.
However, for brain tumours that are sur-
rounded by the normal brain tissues, the
tumour boundaries are more difficult to differ-
entiate; therefore, skull bone is used as surrog-
ate. The translation and roll errors were less
than 2.6 mm and 1.2, respectively, in Schubert
et al.’s study.24 In particular, the small degree of
rotational errors in this region can be easily
detected by CT images, but not by 2D planar
images, which in turn emphasises the advantage
of applying volumetric imaging in precise
radiotherapy treatment.
Daily MVCT has been used to quantify the
parotid shrinkage during HN treatment. The
parotid glands showed a median-volume
shrinkage of 21% and migrated towards the
patient centre at a rate of 0.22 mm/day.30 In
Han et al.,31 the average parotid volume had
decreased by 36%, which led to a 75% increase
in median dose at the end of treatment. Lee
et al.32 also reported a 15% difference in daily
mean parotid dose, with the total mean dose
increasing from 29.7 Gy to 32.7 Gy. These
results were comparable to studies using other
image guidance systems,1,2 and this implied
that the parotid-dose increment was related to
their migration into the high-dose region.
Moreover, the maximum dose delivery to spinal
cord had increased to 7.6% in average and in
the absence of IGRT performed to verify its
position.31
Regardless of the occasional metal artefacts
arising due to implants, for example, dental
amalgam, kVCBCT also demonstrates good
definition of bone, air and soft-tissue interfaces
in the case of HN, yielding superior results
compared to the 2D EPIs.19 Similar to that
observed in MVCT, the tumour is barely visible
in the cranial region, and registration is per-
formed on the basis of parameters related to
bony anatomy. Wang et al.’s study33 showed a
setup error of less than 3 mm in NPC case,
which increased significantly when patients
lost more than 5% of their body weight. With
kVCBCT, Ding et al.34 presented significant
changes in patient’s skin contours and planning
target volume (PTV) contours throughout a
treatment course. More pronounced organ
shrinkage and displacement had been seen in
patients with advanced tumours and in the later
fractions.35
Thoracic and upper-abdomen regions
The treatment uncertainties in these regions are
mainly due to target or organ movement
induced by cardiac and respiratory motion.
The performance of the IGRT systems is
assessed by their ability to visualise these errors.
As the tumour position is sometimes independ-
ent of the bony anatomy, the tumour itself
should become the surrogate instead of the
neighbouring bony structures.
Clearly, volumetric imaging with soft-tissue
visualisation is a more effective approach than
2D planar imaging for verifying the tumour
location in these regions and owing to the lack
of reliable bony reference. Nevertheless, the
MVCT and kVCBCT image quality is subopti-
mal due to their slow CT imaging feature. The
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tumour is usually blurred or distorted because it
is visualised during motion. Although the
patient’s breathing induced blurring of organ
boundaries in images, accurate discrimination
remains possible in kVCBCT images, especially
for lungs, kidneys, liver and spinal cord.19
Nonetheless, it is difficult to separate the
blurred tumour from the thoracic wall, medias-
tinum or the diaphragm if the tumour is situated
close to them.36 The inter-fractional error in
pulmonary case was 7.7 mm  1.3 mm.37 In
the case of breast region, using partial gantry
rotation during kVCBCT also gives acceptable
images of chest wall, heart and lungs for setup
correction.19
When using MVCT, the errors in the case of
visualising lungs were found to be less than 6.1
mm in translation and less than 1 in roll rota-
tion,24 but could be as high as 17 mm in the
antero-posterior (AP) direction.38 Compared
to these organs, however, it was liver that was
shown to have the largest of displacements and
shape changes in the supero-inferior (SI) and
AP directions.38 However, MVCT significantly
reduced setup error in oesophageal tumour; as a
result, a smaller PTV margin could be applied
with the possibility of lesser irradiation of the
lungs.39 Furthermore, some studies have
demonstrated the ability of daily MVCT to
monitor the tumour regression in the lungs.
The average regression rate was shown to be
1.2% per day40 with the dose received by 95%
gross tumour volume (GTV) and an average
increase in radiation by 0.1% per day.
The relatively slower MVCT and kVCBCT
scan reflects the motion-encoded tumour posi-
tion rather than the snap-shot position as in
the case of PLCT. The different presentation
makes registration between the two image sets
inappropriate and results in large patient-to-
patient variation in translational errors. The
organ movement can be corrected using res-
piration-correlated 4DCT to define the
motion-encompassing CTV and PTV. The
contoured 4DCT is then used for treatment
planning and subsequent daily setup verification
with MVCT and kVCBCT. This method
proved to be adequate and allowed setup-error
reduction from 5.2 mm to less than 2.0 mm.41
Another option would be to overlay the con-
tours from the 4DCT on the normal PLCT
and use them for planning and registration. In
this approach, for adequate dose delivery to
the tumour, one should ensure that the
blurred tumour lies entirely within the
motion-encompassing PTV.
Pelvic region
The most prominent factor that limits the
accuracy of treatment delivery in pelvic region
is the organ deformation and displacement
between fractions. Unlike periodic respiratory
motion, these changes are more unpredictable
and may alter the body-surface contour. This
reduces the accuracy of treatment setup using
external skin marks. An effective IGRT system
for this region should provide high image con-
trast to differentiate various organs and visualise
their changes. Due to the independent move-
ment relative to bony structures, soft-tissue
tumour and surrounding OARs should be
used as the surrogate for precise verification.
Due to the rectum- and bladder-volume
changes, there is substantial movement of the
prostate, cervical and endometrial tumours
between fractions. Santanam et al.42 presented
the setup error of 1.3 to 4.8 mm for gynaecolo-
gic malignancies. In Schubert et al.’s study24
that dealt with prostate tomotherapy, the errors
detected were less than 7.2 mm in translation
and 0.5 in roll rotation, with a particularly
large error in the vertical direction. This was
due to the sagging of couch when it was largely
extended into the gantry bore. As the effect of
couch sag increases with body weight,43 image
guidance is of great benefit for heavier patient
to correct this setup uncertainty. In prostate
cancer, MVCT registration was mainly based
on the tumour and detectable bladder.24 How-
ever, it was shown that the volume change in
bladder could be as large as 50%.38 Moreover,
because the primary goal is to track the prostate
position and deliver adequate dose to it, the
dosages to the bladder and the rectum are fre-
quently in variance with the treatment plan,
particularly due to their random daily filling.44
Dose-guidance radiotherapy would be needed
to monitor these OARs doses. In some cases,
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due to the inferior soft-tissue contrast provided
by MVCT, the prostate and bladder may fuse
together in image. Using implanted marker as
surrogate could be a way to improve the veri-
fication accuracy and reduce inter-observer
variance.45 With daily MVCT, Fiorino et al.46
also illustrated that the excellent effect of rec-
tum emptying drastically reduced prostate
motion, reflected by only 5% of fraction that
required 3 mm shifting.
Moseley et al.47 showed that the accuracy
levels demonstrated by kVCBCT for prostate
radiotherapy setup correction are comparable
to that demonstrated by MV portal images.
The ability of kVCBCT to visualise soft-tissue
organs was an advantage, but the boundaries
of prostate, bladder and rectum were only par-
tially differentiable.19 These uncertainties in
the kVCBCT images increased again the inter-
observer errors during the registration process.
Similar to MVCT, implanted prostate markers
could be used to facilitate the alignment process
and help increase the verification accuracy. In
marker-based IGRT using kVCBCT, the pro-
state displacement of 3 mm was shown in 82
out of 96 fractions and mostly in the postero-
inferior direction.48 Moreover, the prostate
could be deformed to in varying degrees.
Thus, shifting and deformation were highly
correlated with the rectal state, but not much
with bladder.38,48 The result implied that there
was indeed benefit in emptying the rectum
before PLCT and treatment so that the prostate
movement could be minimised.
Many factors can affect the image quality of
kVCBCT in pelvic region. Basically, better
soft-tissue contrast is gained with smaller patient
size, full bladder and gas-filled rectum
(airtissue interface). It is shown that the blad-
der dome was easier to distinguish than the
bladder base or prostate apex, and a clear
boundary could be seen at the prostaterectum
interface. In general, images in the sagittal and
coronal planes are more differentiable. Specific-
ally, confident tumour localisation in bladder-
and rectal-cancer patient could be achieved
using kVCBCT, but it is not possible in the
case of prostate because of the unclear presenta-
tion of the prostate apex and base in images.19
As the prostate displacement cannot be accur-
ately quantified, reduction of PTV margin
should be performed with caution.
RECENT DEVELOPMENT
Though CT-based IGRT has enhanced the
capability of verification in radiotherapy, there
is still scope for improvement, which is further
discussed in the following sections.
Soft-tissue contrast
One prerequisite for implementing IGRT is the
provision of adequate anatomical information
for accurate patient alignment. The CT-on-rails
provides the best image contrast among the four
types of in-room CT-imaging techniques dis-
cussed here. Developments related to conven-
tional CT scanner, such as high-resolution
CT, have been reported in some studies.49,50
For the CBCT and MVCT systems, the soft-
tissue visualisation is inferior, and the blurring
of soft-tissue boundaries, regardless of organ
motion, can mislead therapists in their clinical
judgments and, in turn, result in inaccurate
shifting of patients’ position. If uncertainties
are present in defining the target during treat-
ment, it is a potential hazard, rather than merit,
to reduce the margin through the use of image
guidance systems because this conversely
increases the risk of target missing. In some
treatment regions, implanted markers continue
to be used to assist the verification process, but
they carry the risk of infection and are not
effective in assessing organ rotation and
deformation. Therefore, improvement of the
image contrast in these two verification modal-
ities is needed.
The problem of metal artefacts in kVCBCT
images can now be reduced by modifying the
projection data using metal artefact-suppressing
algorithm. Reconstructed kVCBCT images of
more advanced systems have improved soft-tis-
sue visibility near the metal object.51 The large
amount of scatters at the imaging can be
reduced by some physical modifications, for
example, separating the region into two scans
(i.e. decrease FOV) or optimising the source-
to-detector distance.52 Adding anti-scatter grids
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can not only improve contrast but also increase
the noise.53 Recently, a scatter-noise-suppres-
sion algorithm to correct scatter during image
reconstruction has been reported.54 Specifically,
x-ray-intensity-shaping filters (bowtie filters)
have been used in CT scanners for years, and
its usage is now extended to the kVCBCT sys-
tem. Bowtie filter flattens the beam profile
across the detector by maximising the primary
beam to the thicker body centre while reducing
it to the thinner peripheral body part. Reduc-
tion in primary beam at periphery reduces scat-
ter at the detector. The primary beam reduction
also prevents detector saturation by cutting out
excessive signals. Phantom studies demonstrated
the bowtie filter had good performance on
kVCBCT images, with spatial non-uniformity
decreased from 9.8% to 2.1% and almost 100%
CT-number recovery at periphery.55,56 The
overall image quality and CT-number accuracy
(21HU) were improved owing to the reduc-
tion of scatters and beam hardening. The
patient dose was reduced by 26 to 43%. The
bowtie filter has already been implemented to
the kVCBCT system in some centres. How-
ever, like CT imaging, the influence of the filter
selection, patient size and patient centring in the
scan field on kVCBCT image contrast and dose
should be quantified to maximise its usage in
future.57
Like kVCBCT, MVCBCT images also suffer
from image noise and x-ray scatter produced by
cone-beam reconstruction technique. More-
over, the fact of low-quantum efficiency of
EPID and the Compton scattering effect on
MV energies also hinder its soft-tissue sensitiv-
ity. In order to achieve image quality similar
to that of kVCT, a prohibitively large dose,
for example, 50 to 200 cGy have to be applied
if MVCBCT is used. Recently, efforts have
been made to modify the imaging detector
with new scintillation materials in order to
increase its efficiency and dynamic range5860
for better soft-tissue visualisation while main-
taining the dose at 4 to 16 cGy. There are also
clinical data showing the feasibility of using
lower dose (1.8 cGy) MV cone-beam images
for treatment verification.16 Besides, there are
ongoing studies on using diamond and graphite
instead of tungsten as target material for x-ray-
beam generation during MVCBCT. 61,62 In
lower energies (4 MV) and without using the
flattening filter, the spatial resolution was greatly
improved with the use of these alternatives,
especially with the diamond target. Last but
not the least, the tomotherapy system provides
the post-processing function of ‘TomoImage
Filter’, which helps reduce noise and subse-
quently improves the image quality.
Contrast agent is also being suggested to
increase low-contrast delectability in kV
CBCT. It shows benefit over implant markers
which will be present in the follow-up exami-
nations such as MRI or CT after the radio-
therapy course. Intravenous contrast helps
visualise the hepatic vessels and tumours, which
allows higher setup accuracy on liver IGRT.63
Currently, a contrast-enhanced biodegradable
surgical marker which can be imaged with
CBCT, MVCT and EPID is under investiga-
tion.64 For MVCT, contrast enhancement may
be given by a low-density agent such as air-rec-
tal balloon.17 Before widely applied, more stud-
ies should be carried out on the types of contrast
agents used and development of safety protocols
according to injection time, patient’s site and
condition.
Digital tomosynthesis (DTS)
A new imaging technique, digital tomosynthesis
(DTS), has recently been introduced in the
kVCBCT system. It reconstructs the volumetric
images with substantially fewer image projec-
tions acquired through limited gantry rotation
(e.g. 40), while maintaining good image qual-
ity for treatment verification. In brief, initial
image projections are acquired with gantry rota-
tion centred at AP or lateral direction, yielding
stacks of 3D DTS slices in coronal or sagittal
planes, respectively. Due to the finite scan
angle, high-quality axial DTS slices cannot be
obtained. Similar to kVCBCT, the 3D DTS
images are reconstructed using the Feldkamp
filtered back-projection algorithm. The refer-
ence DTS images are generated from the
PLCT data and are registered to the treatment
DTS images for setup verification. In contrast
to kVCBCT, the DTS only requires narrow
scan angle and, therefore, can be used in
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patients with peripheral target, for example,
breast, to solve the problem of geometrical
clearance needed for full gantry rotation. Smal-
ler arc also means lower imaging dose delivered
to patients during image guidance process. Fur-
thermore, the DTS scan can be completed in a
shorter time, less than 5 seconds. This feature is
desirable for imaging tumours in chest and
abdominal regions, which are prone to organ
movement.65
Several studies have been conducted to
quantify the advantages of DTS technique.
Godfrey et al.66 studied the DTS performance
on HN, liver and prostate case and presented
similar image appearance between DTS and
kVCBCT. In particular, DTS images showed
clearly the bladder, prostate and rectum bound-
aries enabling target localisation. With breath
holding, the DTS image is good at visualising
the liver. Without breath holding, the DTS
images still provide better visibility over free-
breathing kVCBCT due to the shorter scan
time. Wu et al.67 and Zhang et al.68 presented
that the DTS position accuracy was only 1 to
3 mm different from kVCBCT, which was
regarded as satisfactory. Dose reduction was
shown in all the studies mentioned previously
under this section. Nevertheless, Zhang et al.
experienced difficulties in identifying the
breast-tumour bed in DTS images and empha-
sised that there was insufficient information of
DTS images for monitoring tumour-volume
changes.
The above-mentioned advantages of the
DTS system indicate that it is a potential altern-
ative to kVCBCT imaging, but studies are still
limited in this area. Extensive investigations
involving more samples in various treatment
sites on quantification of dose reduction and
optimisation of imaging parameters should be
carried out to aid its full implementation in
IGRT.
4D and fluoroscopic imaging with IGRT
system
The impact of intra-fractional errors is not dis-
cussed in details in this article but should not
be neglected. It is well known that the organ
motion due to breathing limits the delivery
accuracy. Respiration-correlated 4D CBCT,
similar to 4DCT, is introduced to verify the
position, shape and trajectory of the moving
tumour and enables safe delivery of gated
IMRT.6971 Active breathing control (ABC)
is also integrated to the kVCBCT system for
breath-hold radiotherapy.72 Zhang et al.73 sug-
gested a new 4D tomotherapy technique that
utilises dynamic 4DCT data for treatment plan
optimisation. In addition, 4D MVCT data can
be acquired and sorted on the basis of respira-
tion phase which allows offline review of target
motion.74,75
Real-time tracking of tumour motion and
position using IGRT system also become a
popular topic, as it allows monitoring of unpre-
dictable infra-fractional organ movement like
prostate motion. Such monitoring technique is
beneficial to prolonged hypofractionated treat-
ments where high dose per fraction is pre-
scribed. The fluoroscopy function could also
be integrated with gating technique to obtain
4D images during gated IMRT treatment.
The technology of kV fluoroscopic imaging
during MV therapy, given by the kVCBCT sys-
tem, is continuously evolving. There were clin-
ical evidences on its feasibility in assessing the
infra-fractional displacement of prostate76 and
real-time tracking of moving fiducial markers.77
However, this technique suffers from MV-
beam scatter on the kV images78 and its lack
of ability to visualise the beam’s eye view
(BEV). The treatment source itself can be used
for fluoroscopic imaging. Utilising the high-
energy treatment beam allows noise reduction
and low-contrast enhancement during image
generation. In addition, the modality does not
require extra time and dose for treatment veri-
fication. However, this technique has some
inherent problems. The constantly changing
fluence and multiLeaf collimator (MLC) pattern
during IMRT treatment induces difficulties in
acquiring acceptable images. Also, the anatom-
ical information given by the image may be
inadequate for verification, owing to the fact
that the treatment beam only target to the
tumour for therapeutic purpose. Nevertheless,
the MV fluoroscopy has been successfully used
to evaluate the stability of liver position during
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ABC treatment.79 Investigation has also been
carried out on collecting MVCT image during
tomotherapy treatment.80 The real-time CT
data that reflect immediate organ position in
3D aspect would be more useful for treatment
verification.
kV/MV in-line CBCT system
Recently, Siemens has introduced the
ARTISTE system, which integrates the
kVCBCT system to the LINAC using an ‘in-
line’ approach. This implies that the x-ray tube
is mounted in a retractable arm adjacent to the
EPID while the flat-panel detector is placed
beneath the MLC system at the gantry head.
The imaging beam and the treatment beam are,
therefore, opposite to each other, with their
central axes aligned and sharing the same isocen-
tre. This setting potentially provides kV or MV
to 2D, 3D cone beam, 4D, as well as real-time
image acquisition. Optimal modalities can be
selected according to the treatment site’s charac-
teristics and treatment technique used. During
monitor unit calculation, a factor must be
applied to account for the presence the kV image
detector between the therapy beam and the
patient.81 Other than this, there is no impact of
the detector on the dose distribution profile.
This kV/MV in-line CBCT system presents sev-
eral advantages. It is less bulky than those cur-
rently used in most centres (refer to previous
descriptions of this article). With the unique
geometry, wide field image can be captured in
line within the BEV (i.e. rotated 180) during
kV fluoroscopy, which facilitates the motion ve-
rification of target or OARs during treatment.
CLINICAL IMPACTS AND
CONCLUSION
Compared to EPIDs, which can only produce
2D images, in-room CT IGRT systems defi-
nitely show advances in providing target visua-
lisation and real-time tracking function which
allow more precise radiotherapy treatment. Fur-
thermore, the implementation of these systems
contributes to the advancements in the field of
radiotherapy. The vast data on geometrical
errors acquired by the IGRT systems provide
the basis to review the reproducibility of certain
immobilisation systems and make improvement.
Close monitoring in organ size and shape pro-
vides opportunities to analyse the radiation
response that expands the radiobiologic know-
ledge. Today, great strides have been made
from IGRT to adaptive radiotherapy (ART).
By projecting the planned beam fluence to the
CT data acquired by the IGRT systems, dose
distribution on a specific treatment day can be
calculated for dose verification. Treatment plan
can then be revised according to the dose
changes, and hence, to restore the planned
dose to both the tumour and OARs. Practically,
there are still many obstacles, such as increased
workload, related overheads, system mainten-
ance and manpower arrangement that hinder a
comprehensive implementation of the IGRT
systems. After all, these IGRT systems are con-
stantly evolving in terms of robustness and effi-
ciency in acquisition, registration and dose
calculation process, and moving towards pro-
viding customised solutions for each and every
patient. It is expected that the 3D CT-based
IGRT system will take over the conventional
2D imaging in future. Besides, IGRT should
be examined with systematic study to give con-
crete data on their long-term clinical outcomes,
including tumour control or normal tissue com-
plications. Practical strategies and workflow
should also be established.
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